Related Experiment Video

Updated: Jun 14, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Extrahepatic manifestations associated with chronic hepatitis C infections in Poland

D A Zarebska-Michaluk1, D M Lebensztejn, W M Kryczka

  • 1Department of Infectious Diseases, Provincial Hospital, Kielce, Poland.

Advances in Medical Sciences
|April 8, 2010
PubMed

Insights

Most patients with chronic hepatitis C (CHC) in Poland experience extrahepatic manifestations (EM). Lower platelet count is a key predictor of these CHC-associated conditions.

Area of Science:

  • Hepatology
  • Immunology
  • Internal Medicine

Background:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Extrahepatic manifestations (EM) are common complications of CHC, impacting various organ systems.
  • Understanding the prevalence and predictors of EM in CHC is crucial for patient management.

Purpose of the Study:

  • To determine the frequency of extrahepatic manifestations (EM) in Polish patients with chronic hepatitis C (CHC).
  • To identify factors that predict the occurrence of EM in this patient cohort.

Main Methods:

  • A study of 340 treatment-naïve CHC patients in Poland (2000-2006).
  • HCV infection confirmed by serology and RNA.
  • Assessment of liver inflammation and fibrosis using Ishak scoring.
  • Exclusion of patients with cirrhosis, co-infections (HBV, HIV), autoimmune liver disease, or alcohol abuse.

Main Results:

  • Over 60% of CHC patients (61.7%) exhibited at least one EM.
  • Common EM included cryoglobulinemia (37.1%), thrombocytopenia (27.6%), thyroid autoimmunity (16.2%), and type 2 diabetes (4.1%).
  • Multivariate analysis identified a lower platelet count as a significant predictor of EM in CHC patients.

Conclusions:

  • A high prevalence of EM is observed in Polish CHC patients.
  • Cryoglobulinemia, thrombocytopenia, thyroid autoimmunity, dermatological disorders, and type 2 diabetes are the most frequent EM.
  • Lower platelet count is a predictive factor for EM in chronic hepatitis C.
Abstract

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...